![Han Myint](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Han Myint formerly worked at NexImmune, Inc., as Chief Medical Officer, Celgene LLC, as Vice President-Global Medical Affairs, the University of Colorado Denver, as Professor-Medicine, and NextCure, Inc., as Chief Medical Officer from 2021 to 2024.
Dr. Myint received his undergraduate degree from the University of Medicine 1.
Former positions of Han Myint
| Companies | Position | End |
|---|---|---|
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 01/07/2024 |
University of Colorado Denver
 University of Colorado Denver Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Celgene LLC | Corporate Officer/Principal | - |
| NEXIMMUNE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Han Myint
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Celgene LLC | |
University of Colorado Denver
University of Colorado Denver Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
University of Medicine 1
 University of Medicine 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Han Myint
